Hydralazine Does Not Require Tapering and Is Not Associated with Rebound Hypertension
Hydralazine can be discontinued abruptly without tapering, as it is not associated with rebound hypertension. This is in stark contrast to centrally-acting agents like clonidine, which require careful tapering to avoid hypertensive crisis.
Key Distinction: Clonidine vs. Hydralazine
The evidence clearly distinguishes between agents that cause rebound hypertension and those that do not:
Clonidine requires tapering: The 2017 ACC/AHA guidelines explicitly warn that "clonidine must be tapered to avoid rebound hypertension" and state to "avoid abrupt discontinuation of clonidine, which may induce hypertensive crisis" 1. The 2018 AHA Scientific Statement on resistant hypertension similarly notes that "clonidine tablets should be avoided because of the need for frequent administration and the risk of rebound hypertension during periods of nonadherence and after discontinuation" 2.
Hydralazine does not cause rebound hypertension: No guideline or FDA labeling mentions rebound hypertension as a concern with hydralazine discontinuation 3, 4, 5, 1, 6, 1, 7. The drug can be stopped without tapering.
Hydralazine Pharmacology and Discontinuation
Hydralazine has a prolonged duration of action that actually protects against abrupt blood pressure changes upon discontinuation. Research demonstrates that after stopping hydralazine, blood pressure returns to baseline gradually over 30-140 hours (1.25-5.8 days), with a multiexponential elimination pattern including a prolonged terminal phase 8. This extended pharmacologic effect means there is no sudden loss of blood pressure control when the drug is stopped.
The 2017 ACC/AHA guidelines note that hydralazine's "BP begins to decrease within 10–30 min, and the fall lasts 2–4 h" for IV administration, with "unpredictability of response and prolonged duration of action" 3, 4, 5, 6. This prolonged action applies to oral formulations as well.
Clinical Considerations When Discontinuing Hydralazine
While tapering is unnecessary, consider these factors:
Ensure adequate alternative antihypertensive coverage: If discontinuing hydralazine as part of a regimen change, ensure other blood pressure medications are optimized before stopping it, as blood pressure may gradually rise over several days.
Monitor for lupus-like syndrome resolution: If discontinuing due to drug-induced lupus (which occurs at doses >150 mg/day), symptoms typically regress after discontinuation, though residua may persist 7.
Address underlying sympathetic activation: Hydralazine causes reflex tachycardia and increased sympathetic tone 2, 7. When used appropriately, it should be combined with a beta-blocker and diuretic. If discontinuing hydralazine while continuing these agents, no adjustment is typically needed.
Common Pitfall to Avoid
Do not confuse hydralazine with clonidine or other centrally-acting agents. The requirement for tapering applies to:
- Clonidine (oral and patch)
- Beta-blockers (which should be tapered to avoid rebound tachycardia and potential cardiac events, though not specifically rebound hypertension)
Hydralazine is a direct-acting vasodilator with an entirely different mechanism and does not share the rebound phenomenon seen with sympatholytic agents.